Ovarian endometrioid stromal and related neoplasms

Summary

Ovarian endometrioid stromal and related neoplasms (MONDO:0003312) is a disease. A subtype of ovarian neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	ovarian endometrioid stromal and related neoplasms
Mondo ID	MONDO:0003312
DOID	DOID:5169
NCIT	C40065
UMLS	C4288544
MedGen	926076
Anatomy (UBERON)	UBERON:0000992
Is cancer (heuristic)	no

Also known as: endometrioid stromal and related neoplasms of ovary · ovarian endometrioid stromal and related neoplasms · ovary endometrioid stromal and related neoplasms

Disease family

This is a subtype of ovarian neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › reproductive system disorder › gonadal disorder › ovarian disorder › ovarian neoplasm › ovarian endometrioid stromal and related neoplasms

Related subtypes (7): ovarian melanoma, ovarian benign neoplasm, ovarian epithelial tumor, rete ovarii neoplasm, ovarian cancer, ovarian germ cell tumor, ovarian sex cord-stromal tumor

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.